You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD138

Showing 1 - 25 of 807
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Immune System Diseases Trial in Chapel Hill (CAR138 T Cells)

Recruiting
  • Multiple Myeloma
  • Immune System Diseases
  • CAR138 T Cells
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Jan 10, 2023

Infertility Trial in Changsha (Endometrial biopsies)

Completed
  • Infertility
  • Endometrial biopsies
  • Changsha, Hunan, China
    Reproductive & Genetic Hospital of CITIC-XIANGYA
Jan 9, 2022

RRMM Trial in Lishui, Wenzhou (CAR-T therapy in Relapsed/Refractory multiple myeloma)

Unknown status
  • RRMM
  • CAR-T therapy in Relapsed/Refractory multiple myeloma
  • Lishui, Zhejiang, China
  • +2 more
Nov 16, 2020

Infertility Unexplained Trial in Krakow (Ofloxacin + Metronidazole)

Active, not recruiting
  • Infertility Unexplained
  • Ofloxacin + Metronidazole
  • Krakow, Malopolska, Poland
    Jagiellonian University Medical College, Department of Gynecolog
Jul 7, 2023

Multiple Myeloma Trial in Suzhou (CART-138/BCMA/19/more)

Recruiting
  • Multiple Myeloma
  • CART-138/BCMA/19/more
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Apr 30, 2019

Chronic Endometritis Trial in Beijing (Antibiotics)

Completed
Has Results
  • Chronic Endometritis
  • Beijing, Beijing, China
    FuXing Hospital,Capital Medical University
Feb 3, 2022

The Aim is to Identify Recurrent Genomic Mutations and/or

Not yet recruiting
  • Multiple Myeloma
  • DNA sequencing
  • Pierre Benite, France
    Hospices Civils de Lyon
Apr 12, 2022

Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)

Recruiting
  • Multiple Myeloma in Remission
  • MM-specific universal CAR T cells
  • Shenzhen, Guangdong, China
  • +1 more
Aug 23, 2023

Multiple Myeloma Trial in Houston (Belumosudil mesylate)

Not yet recruiting
  • Multiple Myeloma
  • Belumosudil mesylate
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2023

Multiple Myeloma Trial in Roma, Rome (ATAC-seq and ChIP-seq)

Recruiting
  • Multiple Myeloma
  • ATAC-seq and ChIP-seq
  • Roma, Italy
  • +1 more
May 4, 2023

Metastatic Colorectal Cancer Trial in France (FOLFOXIRI, FOLFOX, FOLFIRI)

Recruiting
  • Metastatic Colorectal Cancer
  • Besançon, France
  • +11 more
Jul 26, 2021

Hidradenitis Suppurativa Trial in Sydney (Fostamatinib)

Recruiting
  • Hidradenitis Suppurativa
  • Sydney, New South Wales, Australia
    Holdsworth House Medical Practice
Mar 15, 2022

Autoimmune Diseases Trial in Shenzhen, Guilin (4SCAR T cells)

Recruiting
  • Autoimmune Diseases
  • 4SCAR T cells
  • Shenzhen, Guangdong, China
  • +1 more
Jul 17, 2022

Lymphoma, Primary Effusion Trial run by the National Cancer Institute (NCI) (Daratumumab SC)

Not yet recruiting
  • Lymphoma, Primary Effusion
  • Daratumumab SC
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 23, 2023

Optical Genome Mapping in Characterization of Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Bone Marrow samples collection
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Mar 15, 2023

Screening to Improve Survival in AL Amyloidosis

Recruiting
  • Smoldering Multiple Myeloma
  • Monoclonal Gammopathy of Undetermined Significance
    • Orange, California
    • +5 more
    Nov 16, 2022

    Relapsed/Refractory Multiple Myeloma(MM) Trial in Guangdong (CART therapy in Relapsed/Refractory multiple myeloma)

    Terminated
    • Relapsed/Refractory Multiple Myeloma(MM)
    • CART therapy in Relapsed/Refractory multiple myeloma
    • Guangdong, Guangdong, China
      Southern Medical University Zhujiang Hospital
    Sep 17, 2021

    Confounding Factors of Chronic Endometritis in Reproductive

    Not yet recruiting
    • IVF
      • (no location specified)
      Jan 17, 2023

      Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Metformin XR, Placebo)

      Recruiting
      • Monoclonal Gammopathy of Undetermined Significance
      • Smoldering Multiple Myeloma
      • Metformin XR
      • Placebo
      • Boston, Massachusetts
      • +6 more
      Oct 3, 2022

      Immunophenotyping of Plasma Cells and Immune Effector Cells in

      Not yet recruiting
      • Multiple Myeloma
      • Biological sampling
      • (no location specified)
      Jun 17, 2022

      Recurrent AL Amyloidosis, Refractory AL Amyloidosis Trial in Duarte, Boston, Columbus (Bone Marrow Aspiration and Biopsy,

      Recruiting
      • Recurrent AL Amyloidosis
      • Refractory AL Amyloidosis
      • Biospecimen Collection
      • +9 more
      • Duarte, California
      • +10 more
      Jan 19, 2023

      Blood Loss, Surgical, Fluid Retention Trial in Bern (Hyperoncotic Albumin 20%, Isooncotic Albumin 5%, Ringer's Lactate

      Recruiting
      • Blood Loss, Surgical
      • Fluid Retention
      • Hyperoncotic Albumin 20%
      • +2 more
      • Bern, BE, Switzerland
        Patrick Wuethrich, Department of Anaesthesiology and Pain Therap
      May 25, 2022

      Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in Israel (ixazomib-pomalidomide-dexamethasone)

      Recruiting
      • Multiple Myeloma in Relapse
      • Refractory Multiple Myeloma
      • Afula, Israel
      • +7 more
      Jul 10, 2022

      Circulating Multiple Myeloma Cells As A Biomarker of MGUS And

      Completed
      • a Diagnosis of MGUS or SMM by IMWG Criteria
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        May 18, 2022

        Multiple Myeloma Trial in Ann Arbor (Iodine I 131 Tositumomab)

        Active, not recruiting
        Has Results
        • Multiple Myeloma
        • Iodine I 131 Tositumomab
        • Ann Arbor, Michigan
          University of Michigan
        Mar 16, 2022